Test ID: WDMS
Wilson Disease Mutation Screen, ATP7B DNA Sequencing
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
83697
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Diagnostic confirmation of Wilson disease
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Ceruloplasmin, serum copper, and urine copper studies are recommended prior to submitting sample. Test includes sequencing of exons 1 through 21 and analysis for the common Sardinian promoter mutation.
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Wilson Disease Testing Algorithm in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase chain reaction (PCR)/DNA sequencing are utilized to test for the presence of mutations in all 21 exons and a portion of the promoter of the ATP7B gene.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Wilson Disease Mutation Screen
Aliases Lists additional common names for a test, as an aid in searching
ATP7B gene
External
link
PDF
document
Excel
document
Word
document